Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease

Abstract

Our data indicate that measurement of fecal cCP concentration is a useful biomarker for noninvasive evaluation of intestinal inflammation. Dogs with severe signs of GI disease more often have abnormal markers than dogs having less severe disease.